Intraoperative Imaging Market Size, Share & Trends Analysis Report By Product (iCT, iUltrasound, iMRI, and C-arm), By Component (System, Software, Services), By Application, By End-Use, By Region And Segment Forecasts, 2018 - 2030

Report Overview

The global intraoperative imaging market size was valued at USD 2.64 billion in 2021 and is anticipated to expand at a CAGR of 6.6% during the forecast period. The market growth can be attributed to the increase in the adoption of minimally invasive surgeries coupled with technological advancements. In addition, the increasing prevalence of chronic disorders and the rise in the geriatric population are major factors contributing to the market growth. The global geriatric population has grown dramatically, putting them at risk for various disorders. As per the UN, in 2017, the global population of people aged 60 and above was 962 million, doubling in 2050 to reach over 2.1 billion.

Intraoperative imaging is getting popular as a critical tool for more precise and effective surgeries, which improves patient outcomes while also enhancing workflows and efficiencies for healthcare personnel in and out of the operating room. 

Intraoperative imaging technologies, such as iUltrasound, C-arm, and iMRI, have greatly extended surgical possibilities. The ability to see bones and soft tissue with extreme precision has transformed the surgical care of a variety of disorders, including neurology, orthopedics, cardiology, vascular, and neurology. The constant advances in intraoperative imaging technologies, such as 3D technology and real-time imaging, are expected to boost market expansion. For instance, in March 2021, the FDA granted GE Healthcare clearance for OEC 3D, a surgical imaging system capable of both 3D and 2D imaging. By providing precise volumetric images, OEC 3D aims to set a benchmark for intraoperative 3D imaging for spine and orthopedic surgeries. 

An increase in the adoption of minimally invasive surgeries, which is highly dependent on the imaging chain, as the medical team has to rely on indirect visualization of the surgical field during the entire procedure, is expected to promote market growth. However, constraints such as the high cost of intraoperative imaging systems and an increase in demand for refurbished imaging systems may hinder the market expansion throughout the projected period.

The COVID-19 pandemic has significantly affected the intraoperative imaging market. Delay in surgical procedures is the reason. The medical settings where these imaging systems are used are high-risk areas for the spread of the COVID-19 infection. However, guidelines for safe and effective surgical care will decrease pandemic implications during the forecast period. Furthermore, raw material shortages are causing broad business interruptions, resulting in a decline in imaging equipment manufacturing and transportation disruptions. On the other hand, now that the lockdown limitations have been lifted, the market is gradually getting back to normal. 

Product Insights

The C-arm segment dominated the market and accounted for the largest revenue share of 31% in 2021. This is due to its flexibility to move around the patient, allowing it to achieve the best angle for a high-quality image while keeping the patient comfortable. In addition, developments in terms of technology are likely to drive the segment during the forecast period. For instance, in June 2020, Philips highlighted two key advancements on its Zenition mobile C-arm platform: the new tableside user interface, which allows clinicians to control the C-arm from within the sterile area, decreasing the need for constant communication with the operator and making the system more straightforward to use. Furthermore, intravascular ultrasound (IVUS) for peripheral vascular treatments has been integrated into the Zenition platform, streamlining the operating room (OR) and enhancing efficiency. 

The iMRI segment is expected to grow at a lucrative rate during the forecast period. The iMRI system's high-quality images allow for greater precision in difficult surgeries and provide real-time images, greatly reducing the chances of inaccuracy and the absence of ionizing radiation. These have aided the development of iMRI as a crucial tool for surgeries. The iMRI is commonly used in neurological surgeries since intraoperative scans allow neurosurgeons to assess anatomical and pathological structures, overcome inaccuracies caused by brain displacement, and update neuronavigational data. Other than brain surgeries, iMRI is also used for surgical oncology, radiation oncology, and ophthalmology. 

Application Insights

Based on application, the intraoperative imaging market is segmented into, neurosurgery, orthopedic, ENT surgery, oncology, trauma surgery, cardiovascular, and others. The neurosurgery segment accounted for the largest revenue share of around 31% in 2021. As a result of the increasing burden of neurological disorders, including epilepsy, stroke, Parkinson's disease, migraine, brain tumors, multiple sclerosis, Alzheimer's disease, and other dementias. Intraoperative imaging results are life-changing, allowing neurosurgeons to operate with better precision and accuracy, minimizing the need for additional procedures, and preventing patients from contracting an infection while transferring in and out of the operating room.

The oncology segment is expected to grow at a CAGR of 7.9% during the forecast period. The rising prevalence of cancer globally is expected to increase the demand for advanced diagnostics and imaging techniques for oncology. According to the International Agency for Research on Cancer, in 2020, there were about 19,292,789 new cancer cases and 9,958,133 deaths globally. The application and efficiency of intraoperative imaging devices in guiding tumor resection and vascular craniotomy procedures are expected to aid the growth of this segment.

End-use Insights

The hospital segment dominated the market and accounted for the largest revenue share of 78% in 2021 and is expected to continue its dominance during the forecast period. This can be attributed to the increase in the adoption of technologically advanced intraoperative imaging systems in hospitals for better patient outcomes. For instance, in April 2019, Xuanwu Hospital Neurosurgery Department China, performed the first intracranial resection case using a 3.0T high field intraoperative MRI system, indicating that the Xuanwu Hospital neurosurgery department has entered a new era of precision neurosurgery. 

Furthermore, the number of patients receiving treatment in hospitals for neurological illnesses like epilepsy and brain tumors is on the rise. As per the WHO, epilepsy affects over 50 million individuals globally and accounts for a considerable amount of the global disease burden. The proportion of the general population with active epilepsy is estimated to be between 4 and 10 per 1000 persons. Thus, the increasing prevalence of chronic disorders and the adoption of technically advanced imaging systems are expected to boost this segment’s growth during the forecast period.

Regional Insights

North America held the largest revenue share in 2021, as there is a presence of a significant number of market players in the region and their constant efforts in developing new products, investing in acquisitions, and R&D activities to support easy operations and ensure the availability of authentic medical-grade imaging systems is expected to boost the market growth. For instance, in April 2021, Activ Surgical, a digital surgery pioneer based in the U.S., announced the U.S. Food and Drug Administration (FDA) clearance of the company's ActivSight Intraoperative Imaging Module for enhanced surgical visualization. This imaging module offers surgeons real-time intraoperative visual data and imaging, hence improving patient outcomes and operating room safety.

In Asia Pacific, the market for intraoperative imaging is estimated to witness the fastest CAGR during the forecast period, owing to the increased demand for better imaging devices in the region. Additionally, the increasing prevalence of chronic disorders, coupled with the rising geriatric population, is expected to boost the market growth in the region. As per UNFPA, the geriatric population in the region will triple between 2010 and 2050, reaching close to 1.3 billion people. 

Competitive Insights

The key players are working to improve their product offerings by upgrading their products, leveraging important cooperative drives, as well as considering acquisitions and government approvals to increase their client base and get a larger part of the entire industry. For instance, in September 2021, GE Healthcare agreed to acquire BK Medical, a leader in advanced surgical visualization. With this agreement, BK Medical's active imaging platform will be able to reach new customers and markets around the world. In addition, the combination of GE Healthcare's diagnostic imaging technology and BK's ability to enable decision-making and surgical visualization in the intervention will allow for better decision-making across the healthcare system. The following are some of the major participants in the global intraoperative imaging market:

• GE Healthcare

• Siemens Healthineers AG

• Koninklijke Philips N.V.

• Medtronic

• Ziehm Imaging GmbH

• IMRIS

• Shimadzu Corporation

• NeuroLogica

Intraoperative Imaging Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global intraoperative imaging market based on product, component, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • iCT

  • iUltrasound

  • iMRI

  • C-arm system

• Component Outlook (Revenue, USD Million, 2018 - 2030)

  • System

  • Software

  • Services

  • Installation services

  • Maintenance services

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Neurosurgery

  • Orthopedic

  • ENT surgery

  • Oncology surgery

  • Trauma surgery/ emergency room

  • Cardiovascular

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE